HI homepage

Trending
Fewer than 30% of FDA-cleared AI devices share key safety, adverse event info prior to approval
Does BMI affect AI's accuracy when assessing CT scans?
New GE HealthCare partnership expands access to prostate cancer imaging agent
Repetitive head impact in soccer players increases risk of brain damage, MRI shows
Expert panel develops new breast biopsy guidelines
AI-powered brain tumor segmentation tool earns clearance in US

 The clearance marks a key milestone in the company’s expansion into the North American market. 

artificial intelligence in healthcare
Neuroimaging utilization in emergency departments has increased year-over-year for a decade

Researchers believe their new data could be used to better inform staffing coverage in modern radiology departments. 

Radiology gets 68 new FDA-cleared algorithms

Radiology makes up more than 76% of all of the FDA-cleared clinical AI algorithms. 

stock market nasdaq bulls and bears
Lumexa Imaging raises nearly $463M from successful IPO

“Going public is not a finish line. It’s the beginning of our next chapter,” CEO Caitlin Zulla, MPH, said in prepared remarks Dec. 11. 

launch rocket service technology
Private equity firm launches new AI-powered enterprise imaging platform

NXXIM will integrate all available patient data including radiology images, pathology slides and lab results into a “unified, real-time diagnostic workspace.” 
 

radiation oncology therapy treatment
Pre-op MRI not necessary for all breast cancer patients, new data suggest

In some cases, it may actually be more beneficial for this group of women to forego the extra scans, as they can lead to additional testing, costs and potentially delays in care.

Copper-based radiotracer excels at PSMA imaging
Copper-based PSMA radiotracer shines in clinical trial

The tracer's extended half-life of over three hours could make it a promising candidate for future prostate cancer diagnostics. 

lung cancer screening
Targeting women eligible for both lung and breast cancer screening pays off

“There is enormous potential here, and the [American Cancer Society] is thrilled with the outcome of this study," one investigators says. 

Thumbnail
Radiology provider Lumexa Imaging unveils pricing of IPO

The Raleigh, North Carolina-based company—which formerly went by US Radiology Specialists—is offering 25 million shares of common stock at $18.50 apiece. 

Around the web

Radiology Business
Why RadNet is betting heavily on AI to reshape radiology workflows

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Cardiovascular Business
AI turns mammograms into CVD risk assessments—no outside data required

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

Radiology Business
Fewer than 30% of FDA-cleared AI devices share key safety, adverse event info prior to approval

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.